These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Autoimmune polyglandular syndrome associated with idiopathic giant cell myocarditis. Schumann C; Faust M; Gerharz M; Ortmann M; Schubert M; Krone W Exp Clin Endocrinol Diabetes; 2005 May; 113(5):302-7. PubMed ID: 15926118 [TBL] [Abstract][Full Text] [Related]
47. A case of autoimmune urticaria accompanying autoimmune polyglandular syndrome type III associated with Hashimoto's disease, type 1 diabetes mellitus, and vitiligo. Kasznicki J; Drzewoski J Endokrynol Pol; 2014; 65(4):320-3. PubMed ID: 25185856 [TBL] [Abstract][Full Text] [Related]
48. [Polyglandular autoimmune syndrome type II: epidemiology and forms of manifestation]. Förster G; Krummenauer F; Kühn I; Beyer J; Kahaly G Dtsch Med Wochenschr; 1999 Dec; 124(49):1476-81. PubMed ID: 10629665 [TBL] [Abstract][Full Text] [Related]
49. [Polyglandular autoimmune syndrome type II]. Császár T; Patakfalvi A Orv Hetil; 1993 Jul; 134(29):1591-3. PubMed ID: 8336930 [TBL] [Abstract][Full Text] [Related]
51. [Screening for autoimmune polyglandular syndrome in a cohort of patients with type 1 diabetes mellitus]. Gouveia S; Gomes L; Ribeiro C; Carrilho F Arq Bras Endocrinol Metabol; 2013 Dec; 57(9):733-8. PubMed ID: 24402020 [TBL] [Abstract][Full Text] [Related]
52. The immunobiology and clinical features of type 1 autoimmune polyglandular syndrome (APS-1). Guo CJ; Leung PSC; Zhang W; Ma X; Gershwin ME Autoimmun Rev; 2018 Jan; 17(1):78-85. PubMed ID: 29108822 [TBL] [Abstract][Full Text] [Related]
53. Schmidt syndrome--a rare polyendocrinopathy. Chakrabarti D; Mallik K; Bhattacharyya AK J Indian Med Assoc; 2012 Jun; 110(6):406-7. PubMed ID: 23360049 [TBL] [Abstract][Full Text] [Related]
55. [Psycho-immuno-endocrinology of the thyroid gland]. Šterzl I; Absolonová K; Matucha P Vnitr Lek; 2016; 62(9 Suppl 3):107-114. PubMed ID: 27734702 [TBL] [Abstract][Full Text] [Related]
56. Vitiligo associated with other autoimmune diseases: polyglandular autoimmune syndrome types 3B+C and 4. Amerio P; Tracanna M; De Remigis P; Betterle C; Vianale L; Marra ME; Di Rollo D; Capizzi R; Feliciani C; Tulli A Clin Exp Dermatol; 2006 Sep; 31(5):746-9. PubMed ID: 16803462 [TBL] [Abstract][Full Text] [Related]
57. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Betterle C; Dal Pra C; Mantero F; Zanchetta R Endocr Rev; 2002 Jun; 23(3):327-64. PubMed ID: 12050123 [TBL] [Abstract][Full Text] [Related]
58. Autoimmune polyglandular syndrome type I. A case report. Cinaz P; Bideci A; Haznedaroğlu A; Ezgü FS; Ağaoğlu O; Kürşaklioğlu S Turk J Pediatr; 1997; 39(2):271-5. PubMed ID: 9223927 [TBL] [Abstract][Full Text] [Related]
59. Autoimmune hypogonadism as part of an autoimmune polyglandular syndrome. Maclaren N; Chen QY; Kukreja A; Marker J; Zhang CH; Sun ZS J Soc Gynecol Investig; 2001; 8(1 Suppl Proceedings):S52-4. PubMed ID: 11223374 [TBL] [Abstract][Full Text] [Related]
60. Autoantibodies linked to autoimmune polyendocrine syndrome type I are prevalent in Down syndrome. Söderbergh A; Gustafsson J; Ekwall O; Hallgren A; Nilsson T; Kämpe O; Rorsman F; Annerén G Acta Paediatr; 2006 Dec; 95(12):1657-60. PubMed ID: 17129978 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]